Tyr36
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr36  -  Rin1 (human)

Site Information
kPAQDPLyDVPNAsG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 450778
Available spectra:  1 CST
Associated spectra:  3 CST

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 823 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 )
Disease tissue studied:
atrial fibrillation ( 624 , 638 ) , adenoid cystic carcinoma ( 533 , 535 ) , bile-duct cancer ( 37 , 38 , 39 , 504 , 506 , 507 , 508 , 524 , 570 ) , bladder cancer ( 291 , 292 , 293 , 765 , 767 , 796 , 814 ) , bone cancer ( 17 , 681 , 682 , 683 , 701 , 702 , 703 , 978 ) , Ewing's sarcoma ( 17 , 702 ) , osteosarcoma ( 17 , 681 , 682 , 683 , 701 , 703 , 978 ) , brain cancer ( 4 , 14 , 17 , 74 , 83 , 104 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 519 , 574 , 577 , 578 , 586 , 587 , 588 , 707 , 710 , 773 , 813 , 837 , 838 , 870 , 876 , 880 , 882 , 883 , 884 , 894 , 898 , 899 , 905 , 911 , 970 ) , astrocytoma ( 74 , 83 , 519 , 574 , 707 , 894 , 905 , 970 ) , glioblastoma ( 4 , 104 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 707 , 773 , 837 , 838 , 870 , 876 , 882 , 884 , 898 , 899 , 911 ) , glioblastoma multiforme ( 14 , 577 , 578 , 586 , 587 , 588 , 707 , 710 , 837 , 838 , 876 , 882 , 898 , 911 ) , glioma ( 4 , 14 , 104 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 577 , 578 , 586 , 587 , 588 , 707 , 710 , 773 , 813 , 837 , 838 , 870 , 876 , 882 , 884 , 898 , 899 , 911 ) , Schwannoma ( 17 ) , breast cancer ( 105 , 289 , 290 , 335 , 613 , 614 , 615 , 616 , 617 , 618 , 620 , 621 , 622 , 623 , 628 , 629 , 640 , 670 , 706 , 711 , 712 , 713 , 714 , 715 , 716 , 759 , 760 , 761 , 762 , 779 , 780 , 786 , 787 , 794 , 797 , 798 , 817 , 823 , 827 , 897 , 906 , 907 , 912 , 954 , 955 , 956 , 976 , 982 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 ) , breast adenocarcinoma ( 827 , 906 , 956 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 ) , breast ductal carcinoma ( 897 , 907 ) , luminal A breast cancer ( 1 ) , luminal B breast cancer ( 1 ) , breast cancer, surrounding tissue ( 1 , 289 ) , breast cancer, triple negative ( 105 , 907 , 912 ) , colorectal cancer ( 17 , 42 , 43 , 44 , 65 , 70 , 71 , 80 , 81 , 124 , 125 , 139 , 448 , 449 , 459 , 598 , 600 , 601 , 603 , 675 , 676 , 677 , 678 , 679 , 744 , 832 , 833 , 874 , 875 , 910 , 940 , 941 , 945 , 971 , 972 , 988 , 989 , 993 , 994 , 995 ) , colorectal carcinoma ( 17 , 42 , 43 , 44 , 70 , 71 , 80 , 81 , 675 , 676 , 677 , 678 , 679 , 744 , 832 , 833 , 874 , 875 , 910 , 940 , 941 , 945 , 971 , 972 , 988 , 989 , 993 , 994 , 995 ) , colorectal cancer, surrounding tissue ( 137 , 458 , 481 , 599 , 602 ) , esophageal cancer ( 33 , 34 , 180 , 182 , 183 , 184 , 185 , 186 , 187 , 323 , 324 , 325 , 326 , 329 , 342 , 344 , 345 , 347 , 348 , 350 , 354 , 355 , 361 , 365 , 366 , 369 , 370 , 371 , 372 , 376 , 377 , 378 , 383 , 384 , 388 , 391 , 392 , 393 , 395 , 397 , 399 , 400 , 403 , 404 , 405 , 406 , 407 , 410 , 412 , 413 , 417 , 419 , 420 , 422 , 427 , 428 , 433 , 434 , 435 , 436 , 437 , 439 , 440 , 442 , 443 , 808 , 809 , 810 , 815 , 816 , 862 ) , esophageal carcinoma ( 180 , 182 , 183 , 184 , 185 , 186 , 810 , 815 ) , esophageal cancer, surrounding tissue ( 341 , 343 , 346 , 349 , 351 , 352 , 353 , 356 , 357 , 358 , 359 , 360 , 362 , 363 , 364 , 367 , 368 , 373 , 374 , 375 , 379 , 380 , 381 , 382 , 385 , 386 , 387 , 389 , 390 , 394 , 396 , 398 , 401 , 402 , 408 , 409 , 411 , 414 , 415 , 416 , 418 , 421 , 423 , 425 , 429 , 430 , 431 , 432 , 438 , 441 , 445 ) , liposarcoma ( 17 ) , gallbladder cancer ( 523 ) , gastric cancer ( 16 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 31 , 40 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 72 , 73 , 82 , 148 , 149 , 150 , 151 , 159 , 160 , 161 , 170 , 171 , 172 , 173 , 174 , 175 , 178 , 179 , 181 , 212 , 213 , 217 , 219 , 229 , 271 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 282 , 283 , 285 , 286 , 287 , 453 , 454 , 455 , 456 , 530 , 542 , 544 , 545 , 547 , 548 , 550 , 551 , 552 , 555 , 556 , 557 , 559 , 560 , 562 , 631 , 633 , 634 , 643 , 646 , 647 , 649 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 661 , 662 , 665 , 666 , 667 , 668 , 669 , 671 , 740 , 741 , 742 , 743 , 788 , 834 , 835 , 836 , 841 ) , gastric carcinoma ( 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 31 , 40 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 72 , 73 , 82 , 148 , 149 , 150 , 151 , 159 , 160 , 161 , 170 , 171 , 172 , 173 , 174 , 175 , 178 , 179 , 181 , 217 , 219 , 229 , 453 , 454 , 455 , 456 , 542 , 544 , 545 , 547 , 548 , 550 , 551 , 552 , 555 , 631 , 633 , 634 , 647 , 649 , 651 , 657 , 671 , 740 , 741 , 742 , 743 , 835 ) , gastric carcinoma, surrounding tissue ( 272 , 280 , 281 , 284 , 288 , 543 , 546 , 549 , 553 , 554 , 558 , 561 , 563 , 564 , 632 , 642 , 644 , 645 , 650 , 660 ) , kidney cancer ( 294 , 298 , 300 , 764 ) , kidney cancer, surrounding tissue ( 299 ) , laryngeal cancer ( 607 , 608 , 609 , 610 , 611 ) , laryngeal cancer, surrounding tissue ( 612 ) , leukemia ( 45 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 176 , 190 , 192 , 197 , 200 , 203 , 205 , 206 , 208 , 218 , 222 , 230 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 247 , 332 , 334 , 619 , 635 , 636 , 648 , 659 , 695 , 696 , 697 , 698 , 699 , 700 , 704 , 705 , 729 , 730 , 736 , 737 , 777 , 778 , 790 , 792 , 793 , 802 , 803 , 811 , 830 , 831 , 846 , 847 , 848 , 849 , 850 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 879 , 881 , 901 , 902 , 903 , 904 , 914 , 915 , 926 , 934 , 935 , 936 , 937 , 939 , 946 , 947 , 962 , 966 , 967 , 968 , 969 , 979 , 983 , 985 , 1002 , 1003 , 1017 , 1018 ) , acute lymphocytic leukemia ( 802 , 803 , 1002 ) , acute myelogenous leukemia ( 123 , 730 , 736 , 737 , 790 , 792 , 793 , 811 , 856 , 867 , 868 , 869 , 881 , 914 , 915 , 934 , 935 , 936 , 937 , 939 , 946 , 947 , 962 , 979 , 985 , 1017 , 1018 ) , chronic myelogenous leukemia ( 45 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 176 , 190 , 192 , 197 , 200 , 203 , 205 , 206 , 208 , 218 , 222 , 230 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 247 , 332 , 334 , 619 , 635 , 636 , 648 , 659 , 697 , 698 , 699 , 700 , 704 , 705 , 729 , 777 , 778 , 830 , 831 , 846 , 847 , 848 , 849 , 850 , 855 , 857 , 858 , 859 , 860 , 861 , 863 , 864 , 865 , 866 , 879 , 901 , 902 , 903 , 904 , 926 , 966 , 967 , 968 , 969 , 983 , 1003 ) , liver cancer ( 120 , 295 , 297 , 301 , 303 , 304 , 305 , 306 , 308 , 309 , 310 , 312 , 315 , 316 , 450 , 460 , 461 , 462 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 482 , 503 , 521 , 522 , 525 , 575 , 576 , 594 , 630 , 663 , 664 ) , liver adenocarcinoma ( 630 ) , cholangiocellular carcinoma ( 120 , 308 , 462 , 482 , 594 , 663 , 664 ) , cholangiocellular carcinoma, surrounding tissue ( 302 , 478 , 479 ) , hepatocellular carcinoma ( 301 , 303 , 304 , 305 , 306 , 309 , 310 , 312 , 315 , 316 , 465 , 466 , 469 , 470 , 575 ) , hepatocellular carcinoma, surrounding tissue ( 307 , 311 , 313 , 463 , 480 ) , liver cancer, surrounding tissue ( 296 ) , lung cancer ( 6 , 7 , 8 , 9 , 10 , 11 , 12 , 41 , 66 , 67 , 68 , 69 , 75 , 76 , 77 , 78 , 79 , 84 , 85 , 86 , 87 , 88 , 90 , 98 , 100 , 102 , 158 , 177 , 189 , 191 , 194 , 195 , 196 , 199 , 201 , 202 , 204 , 207 , 210 , 214 , 215 , 248 , 251 , 252 , 255 , 256 , 258 , 260 , 261 , 317 , 318 , 319 , 320 , 321 , 322 , 327 , 328 , 330 , 451 , 452 , 457 , 471 , 472 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 515 , 516 , 520 , 527 , 565 , 567 , 568 , 581 , 596 , 597 , 641 , 671 , 672 , 673 , 674 , 708 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 758 , 766 , 768 , 770 , 779 , 780 , 799 , 800 , 801 , 812 , 818 , 819 , 820 , 822 , 824 , 825 , 826 , 828 , 829 , 845 , 851 , 872 , 873 , 877 , 878 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 895 , 896 , 900 , 908 , 913 , 916 , 917 , 918 , 921 , 922 , 923 , 924 , 925 , 928 , 929 , 930 , 931 , 932 , 933 , 942 , 943 , 944 , 948 , 949 , 950 , 951 , 952 , 957 , 959 , 960 , 961 , 963 , 964 , 965 , 973 , 975 , 977 , 980 , 981 , 984 , 999 , 1000 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1013 ) , non-small cell lung cancer ( 6 , 7 , 9 , 10 , 11 , 13 , 15 , 41 , 66 , 67 , 68 , 69 , 75 , 76 , 77 , 78 , 79 , 84 , 85 , 86 , 87 , 88 , 90 , 158 , 177 , 210 , 248 , 251 , 252 , 255 , 256 , 258 , 260 , 261 , 328 , 451 , 452 , 457 , 471 , 472 , 484 , 485 , 486 , 487 , 515 , 516 , 520 , 565 , 596 , 597 , 641 , 671 , 672 , 673 , 674 , 708 , 717 , 718 , 719 , 723 , 724 , 725 , 726 , 727 , 728 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 754 , 756 , 758 , 768 , 799 , 800 , 801 , 812 , 822 , 824 , 825 , 826 , 828 , 829 , 845 , 851 , 872 , 873 , 877 , 878 , 888 , 889 , 890 , 891 , 892 , 893 , 896 , 900 , 908 , 913 , 916 , 917 , 918 , 921 , 922 , 923 , 924 , 925 , 928 , 929 , 930 , 931 , 932 , 942 , 943 , 948 , 949 , 950 , 951 , 952 , 957 , 959 , 960 , 961 , 963 , 964 , 965 , 973 , 975 , 977 , 980 , 981 , 999 , 1000 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1013 ) , non-small cell lung cancer, surrounding tissue ( 211 ) , non-small cell lung adenocarcinoma ( 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 41 , 68 , 69 , 77 , 78 , 79 , 84 , 85 , 86 , 87 , 88 , 90 , 158 , 177 , 248 , 251 , 252 , 255 , 256 , 258 , 260 , 261 , 451 , 452 , 484 , 485 , 486 , 487 , 520 , 565 , 596 , 597 , 671 , 723 , 724 , 725 , 727 , 728 , 770 , 779 , 780 , 820 , 932 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 89 , 249 , 250 , 253 , 254 , 257 , 259 , 262 ) , non-small cell large cell lung carcinoma ( 6 , 9 , 766 ) , non-small cell squamous cell lung carcinoma ( 8 , 41 , 317 , 318 , 319 , 320 , 321 , 322 , 327 , 330 , 451 , 452 , 488 , 489 , 490 , 491 , 492 , 493 , 567 , 568 , 890 , 913 , 923 , 1007 , 1008 ) , non-small cell squamous cell lung carcinoma, surrounding tissue ( 566 ) , small-cell lung cancer ( 895 , 984 ) , lung cancer, surrounding tissue ( 96 , 97 , 99 , 101 , 103 , 138 , 140 , 193 , 198 , 526 ) , lymphoma ( 785 , 839 ) , Hodgkin's lymphoma ( 785 , 839 ) , neuroblastoma ( 3 , 136 , 154 , 155 , 514 , 774 , 775 , 776 , 781 , 783 , 784 , 840 , 880 , 883 ) , oropharyngeal cancer ( 854 ) , squamous cell carcinoma of the oropharynx ( 854 ) , ovarian cancer ( 35 , 36 , 106 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 152 , 153 , 188 , 216 , 223 , 224 , 225 , 226 , 227 , 228 , 684 , 685 , 686 , 688 , 689 , 690 , 691 , 842 , 843 , 844 , 852 , 853 , 909 ) , ovarian epithelial carcinoma ( 35 , 36 , 106 , 127 , 131 , 152 , 153 , 842 , 852 , 853 ) , pancreatic cancer ( 331 , 986 , 987 , 991 , 992 , 996 , 1001 , 1015 , 1016 ) , pancreatic carcinoma ( 986 , 987 , 991 , 992 , 996 , 1001 ) , pancreatic cancer, surrounding tissue ( 333 , 639 ) , multiple myeloma ( 447 ) , prostate cancer ( 990 , 1011 , 1012 ) , salivary gland cancer ( 510 , 511 , 512 , 513 ) , melanoma skin cancer ( 2 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 483 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 505 , 517 , 518 , 569 , 571 , 572 , 573 , 589 , 590 , 591 ) , non-melanoma skin cancer ( 997 , 998 ) , leiomyosarcoma ( 17 ) , rhabdomyosarcoma ( 17 ) , teratoma, surrounding tissue ( 592 ) , thymic carcinoma ( 91 , 92 , 93 , 94 ) , thyroid cancer ( 625 , 938 ) , follicular thyroid carcinoma ( 938 ) , ventricular tachycardia ( 95 , 107 , 108 , 109 , 110 , 111 )
Relevant cell line - cell type - tissue:
'fat, white' ( 17 ) , 'liver, para-cholangiocellular carcinoma tissue' ( 120 ) , 143.98.2 (bone cell) ( 703 ) , 143B (bone cell) ( 683 ) , 184A1 (epithelial) [HER2 (human), transfection] ( 789 ) , 184A1 (epithelial) ( 314 , 789 , 927 ) , 23132/87 (gastric) ( 29 , 835 ) , 293 (epithelial) [EFNB1 (human), transfection] ( 231 ) , 293 (epithelial) [EphB2 (human), transfection] ( 231 ) , 44-ZW-5409 (eye cell) ( 710 ) , 5637 (bladder cell) ( 796 ) , 639V (renal) ( 764 ) , 703167 (pulmonary) ( 191 ) , 704773 (pulmonary) ( 195 ) , 8-MG-BA (glial) ( 882 ) , A172 (glial) ( 870 ) , A204 (muscle cell) ( 17 ) , A431 (epithelial) ( 997 , 998 ) , A549 (pulmonary) [LKB1 (human), no information] ( 597 ) , A549 (pulmonary) ( 15 , 177 , 596 , 720 , 721 , 722 , 1013 ) , A673 (muscle cell) ( 17 ) , ACC-S (adenoidal) ( 532 , 534 ) , ACN ( 783 ) , AZ-521 (gastric) ( 654 ) , BC-3C (bladder cell) ( 765 ) , BEAS-2B (epithelial) [LKB1 (human), no information] ( 475 ) , BEAS-2B (epithelial) ( 473 , 474 ) , bladder ( 291 , 292 , 293 ) , brain ( 837 , 838 ) , breast ( 1 , 289 , 290 , 613 , 614 , 615 , 616 , 617 , 618 , 620 , 621 , 622 , 623 , 628 , 629 , 640 , 670 , 706 , 786 , 787 , 797 , 798 ) , BT-20 (breast cell) ( 105 , 715 , 716 ) , BT-474 (breast cell) ( 335 ) , BT-549 (breast cell) ( 105 ) , BV-173 (myeloid) ( 855 , 968 , 983 ) , BxPC-3 (pancreatic) ( 1015 , 1016 ) , Caki-2 (renal) ( 795 , 805 , 807 ) , Cal-12T (pulmonary) ( 11 , 900 ) , CAL-85-1 (breast cell) ( 827 ) , Calu-3 (pulmonary) ( 7 , 933 ) , cardiac-heart ( 108 , 110 , 111 ) , CAS-1 (glial) ( 773 ) , CCF-STTG1 (glial) ( 905 ) , cholangiocyte-liver ( 308 , 462 , 482 , 594 , 663 , 664 ) , CHP212 (neural crest) ( 3 , 880 ) , CMS (myeloid) ( 782 , 792 , 793 ) , COLO-680N (esophageal) [RAIG1 (human), knockdown] ( 33 ) , COLO-680N (esophageal) ( 34 , 187 , 816 , 862 ) , colon ( 124 , 125 , 137 , 139 , 448 , 449 , 458 , 459 , 481 , 598 , 599 , 600 , 601 , 602 , 603 ) , Detroit562 (squamous) ( 854 ) , DK-MG (glial) ( 876 ) , DLD1 (intestinal) ( 17 , 65 ) , DMS153 (pulmonary) ( 10 ) , DU 145 (prostate cell) ( 1011 , 1012 ) , DV-90 (pulmonary) ( 819 ) , EFM-19 (breast cell) ( 105 , 804 ) , EFO-21 (ovarian) ( 843 ) , EGI-1 (bile-duct cell) ( 570 ) , ES2 (ovarian) ( 842 , 852 ) , esophagus ( 323 , 324 , 325 , 326 , 329 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 425 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 445 ) , FU97 (gastric) ( 212 , 213 , 655 ) , G-292 (bone cell) ( 701 ) , germ cell-teratoma ( 592 ) , GI-CA-N (neural crest) ( 3 , 774 ) , GI-LI-N (neuron) ( 784 ) , GI-ME-N (neuron) ( 3 , 781 ) , glial-brain ( 4 , 14 ) , HBEC3 (epithelial) [EGFR (human), transfection, EGFR (DelA746-A750)] ( 581 ) , HBEC3 (epithelial) [EGFR (human), transfection, EGFR (L858R)] ( 581 ) , HBEC3 (epithelial) [EGFR (human), transfection, EGFR (WT)] ( 581 ) , HBEC3 (epithelial) [KRas (human), transfection, K-Ras (G12V)] ( 581 ) , HCC1143 (breast cell) ( 105 , 907 ) , HCC1395 (breast cell) ( 105 , 897 ) , HCC1428 (breast cell) ( 105 , 906 ) , HCC15 (pulmonary) ( 8 , 845 ) , HCC1569 (breast cell) ( 105 ) , HCC1599 (breast cell) ( 105 , 759 , 760 ) , HCC1806 (breast cell) ( 105 , 912 ) , HCC1937 (breast cell) ( 105 ) , HCC202 (breast cell) ( 711 , 712 ) , HCC366 (pulmonary) ( 961 ) , HCC38 (breast cell) ( 105 ) , HCC44 (pulmonary) ( 11 , 952 ) , HCC70 (breast cell) ( 105 ) , HCC78 (pulmonary) ( 9 , 68 , 69 , 78 , 79 , 520 , 799 , 951 ) , HCC827 (pulmonary) ( 7 , 158 , 177 , 671 , 723 , 724 , 725 , 932 ) , HCT116 (intestinal) ( 42 , 43 , 44 , 70 , 71 , 80 , 81 , 744 , 833 , 971 , 972 , 988 , 989 , 993 , 994 ) , HD-MyZ (myeloid) ( 785 , 839 ) , HDQ-P1 (breast cell) ( 105 , 817 ) , heart ( 95 , 107 , 109 , 624 , 626 , 627 , 637 , 638 ) , HeLa (cervical) ( 5 , 122 , 220 , 221 , 509 , 579 , 582 , 583 , 584 , 585 ) , hepatic-'liver, para-cholangiocellular carcinoma tissue' ( 302 , 478 , 479 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 307 , 311 , 313 , 463 , 480 ) , hepatocyte-liver ( 301 , 303 , 304 , 305 , 306 , 309 , 310 , 312 , 315 , 465 , 466 ) , HepG2 (hepatic) ( 316 ) , HES-3 ('stem, embryonic') ( 121 ) , HL60 (myeloid) ( 1017 ) , HLE (hepatic) ( 469 ) , HOS (bone cell) ( 682 ) , Hs766T (pancreatic) ( 987 , 1001 ) , HT-29 (intestinal) ( 945 , 995 ) , HT-93 (myeloid) ( 811 , 985 ) , Huh1 (hepatic) ( 470 ) , Huh28 (hepatic) ( 522 ) , Huh7 (hepatic) ( 576 ) , HUVEC (endothelial) ( 536 , 537 , 538 , 539 , 540 , 541 ) , IM95 (gastric) ( 656 ) , J82 (bladder cell) ( 806 ) , JHH-2 (hepatic) ( 525 ) , JHH-4 (hepatic) ( 503 ) , JHH-6 (hepatic) ( 521 ) , JIMT-1 (breast cell) ( 105 , 794 , 823 ) , Jurkat (T lymphocyte) ( 595 ) , K562 (erythroid) ( 45 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 176 , 190 , 192 , 197 , 200 , 203 , 205 , 206 , 208 , 218 , 222 , 230 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 247 , 332 , 334 , 619 , 635 , 636 , 648 , 659 , 697 , 698 , 699 , 700 , 704 , 705 , 729 , 777 , 778 , 830 , 831 , 846 , 847 , 848 , 849 , 850 , 857 , 858 , 859 , 860 , 861 , 863 , 864 , 865 , 866 , 879 , 901 , 902 , 903 , 904 , 926 ) , Kasumi-1 (myeloid) ( 881 ) , KATO III (gastric) ( 836 ) , KCL22 (myeloid) ( 855 , 966 , 967 ) , KELLY (neural crest) ( 3 , 840 ) , kidney ( 294 , 298 , 299 , 300 ) , KPL-1 (breast cell) ( 105 ) , KU812 (myeloid) ( 855 , 969 , 1003 ) , KY821 (myeloid) ( 123 , 936 ) , Kyse150 (esophageal) ( 182 , 810 ) , Kyse180 (esophageal) ( 186 ) , Kyse270 (esophageal) ( 185 , 808 , 809 ) , Kyse30 (esophageal) ( 180 ) , Kyse510 (esophageal) ( 184 ) , Kyse520 (esophageal) ( 183 ) , Kyse70 (esophageal) ( 815 ) , LAN-1 (neural crest) ( 3 , 775 ) , LAN-5 (neural crest) ( 3 , 776 ) , LAN-6 (neural crest) ( 3 , 514 ) , larynx ( 607 , 608 , 609 , 610 , 611 , 612 ) , LCLC-103H (pulmonary) ( 824 ) , liver ( 120 , 295 , 296 , 297 , 460 , 461 , 464 , 467 ) , LN18 (glial) ( 577 , 578 , 586 , 587 , 588 , 898 ) , LN229 (glial) ( 899 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFR (wildtype)] ( 104 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII mutant (aka Delta EGFR, d2-7 EGFR; del. exon 2-7; in-frame loss 801 bp/267 aa in EC domain)] ( 104 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII-ki mutant (deletion of exons 2-7 plus kinase inactive mutation)] ( 104 ) , LN444 (glial) ( 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 ) , LOU-NH91 (squamous) ( 8 , 890 , 923 ) , lung ( 6 , 7 , 8 , 9 , 10 , 11 , 12 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 138 , 140 , 189 , 193 , 194 , 196 , 198 , 199 , 201 , 202 , 204 , 207 , 210 , 211 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 317 , 318 , 319 , 320 , 321 , 322 , 327 , 328 , 330 , 457 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 526 , 527 , 565 , 566 , 567 , 568 , 641 , 672 , 673 , 674 , 708 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 758 , 800 , 801 , 812 , 851 , 877 , 878 , 885 , 886 , 887 , 888 , 916 , 917 , 918 , 919 , 920 , 942 , 943 , 948 , 953 , 958 , 959 , 960 , 964 , 965 ) , LXF-289 (pulmonary) ( 825 ) , M-07e (myeloid) ( 962 ) , Marimo (myeloid) ( 937 ) , MCAS (ovarian) ( 133 ) , MCF-10A (breast cell) [CSFR (human), transfection] ( 134 ) , MCF-10A (breast cell) ( 134 , 954 , 955 , 976 , 982 ) , MDA-MB-134vi (breast cell) ( 105 ) , MDA-MB-175vii (breast cell) ( 105 ) , MDA-MB-231 (breast cell) ( 135 ) , MDA-MB-435S (breast cell) ( 105 , 956 ) , MDA-MB-436 (breast cell) ( 105 , 713 , 714 ) , MDA-MB-468 (breast cell) ( 105 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 ) , MDAH2774 (ovarian) ( 844 ) , ME-F2 (myeloid) ( 869 , 939 ) , MG63 (bone cell) ( 17 , 681 ) , MIA PaCa-2 (pancreatic) ( 991 , 992 ) , MKN-1 (gastric) ( 657 ) , MKN-45 (gastric) ( 16 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 31 , 40 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 72 , 73 , 82 , 148 , 149 , 150 , 151 , 159 , 160 , 161 , 170 , 171 , 172 , 173 , 174 , 175 , 178 , 179 , 181 , 217 , 219 , 229 , 453 , 454 , 455 , 456 , 528 , 529 , 530 , 671 , 740 , 741 , 742 , 743 , 841 ) , MKN-7 (gastric) ( 667 ) , MKN-74 (gastric) ( 668 ) , ML-1 (myeloid) ( 938 ) , MNNG-HOS (bone cell) ( 17 , 978 ) , Molm 14 (myeloid) ( 336 , 867 , 934 ) , MT-3 (breast cell) ( 779 , 780 ) , muscle ( 17 ) , MV4-11 (macrophage) ( 444 , 446 , 735 , 736 , 737 , 738 , 739 , 790 , 935 , 979 , 1018 ) , NCI-H1299 (pulmonary) ( 6 , 177 , 924 ) , NCI-H1355 (pulmonary) ( 818 ) , NCI-H1373 (pulmonary) ( 999 ) , NCI-H1435 (pulmonary) ( 908 ) , NCI-H1437 (pulmonary) ( 10 , 11 , 949 ) , NCI-H1650 (pulmonary) ( 7 , 66 , 67 , 75 , 76 , 671 , 921 , 922 , 929 , 981 , 1014 ) , NCI-H1666 (pulmonary) ( 11 , 671 , 931 , 977 , 980 ) , NCI-H1693 (pulmonary) ( 925 ) , NCI-H1703 (squamous) ( 8 , 41 , 337 , 338 , 339 , 340 , 451 , 452 , 717 , 718 , 719 , 963 , 1000 ) , NCI-H1734 (pulmonary) ( 6 ) , NCI-H1781 (pulmonary) ( 9 ) , NCI-H1792 (pulmonary) [LKB1 (human), no information] ( 471 , 472 ) , NCI-H1792 (pulmonary) ( 476 , 477 ) , NCI-H1838 (pulmonary) ( 828 , 893 ) , NCI-H1869 (squamous) ( 913 ) , NCI-H1915 (pulmonary) ( 889 ) , NCI-H1944 (pulmonary) ( 6 ) , NCI-H1975 (pulmonary) ( 7 , 177 , 671 , 930 ) , NCI-H2030 (pulmonary) ( 896 ) , NCI-H2052 (pulmonary) ( 826 ) , NCI-H2066 (pulmonary) ( 873 ) , NCI-H2073 (pulmonary) ( 8 , 10 , 829 ) , NCI-H209 (pulmonary) ( 10 ) , NCI-H2106 (pulmonary) ( 7 ) , NCI-H2135 (pulmonary) ( 872 ) , NCI-H2228 (pulmonary) ( 9 , 13 , 580 , 957 ) , NCI-H226 (pulmonary) ( 1007 , 1008 ) , NCI-H2286 (pulmonary) ( 895 ) , NCI-H2342 (pulmonary) ( 8 ) , NCI-H2347 (pulmonary) ( 973 ) , NCI-H2405 (pulmonary) ( 11 ) , NCI-H2452 (pulmonary) ( 822 ) , NCI-H292 (pulmonary) ( 177 ) , NCI-H3122 (pulmonary) ( 9 , 77 ) , NCI-H358 (pulmonary) [LKB1 (human), no information] ( 516 ) , NCI-H358 (pulmonary) ( 6 , 177 , 515 , 671 , 928 , 975 ) , NCI-H441 (pulmonary) ( 177 , 1009 , 1010 ) , NCI-H460 (pulmonary) ( 6 , 1004 , 1005 , 1006 ) , NCI-H526 (pulmonary) ( 984 ) , NCI-H596 (pulmonary) ( 892 ) , NCI-H647 (pulmonary) ( 891 ) , NCI-H661 (pulmonary) ( 9 , 944 ) , NCI-H838 (pulmonary) ( 10 , 950 ) , NCI-H929 (B lymphocyte) ( 447 ) , nerve ( 17 ) , NKM-1 (myeloid) ( 868 , 947 ) , NOMO-1 (myeloid) ( 730 , 946 ) , NOZ ('epithelial, gallbladder') ( 523 ) , NT2 (testicular) ( 209 ) , NUGC-2 (gastric) ( 665 ) , NUGC-3 (gastric) ( 658 ) , NUGC-4 (gastric) ( 666 ) , OCI/AML3 (myeloid) ( 856 , 914 ) , OCUM-1 (gastric) ( 652 ) , ovary ( 141 , 142 , 143 , 152 , 153 , 188 , 216 , 223 , 224 , 225 , 226 , 227 , 228 , 684 , 685 , 686 , 688 , 689 , 690 , 691 ) , OVCAR8 (ovarian) ( 147 ) , OVKATE (ovarian) ( 126 , 128 ) , OVMANA (ovarian) [RAIG1 (human), knockdown] ( 35 , 36 ) , OVMANA (ovarian) ( 106 , 127 , 131 ) , OVMIU (ovarian) ( 129 ) , OVTOKO (ovarian) ( 132 , 145 , 146 ) , OZ (bile-duct cell) [RAIG1 (human), knockdown] ( 37 , 38 ) , OZ (bile-duct cell) ( 39 , 524 ) , PANC-1 (pancreatic) ( 996 ) , pancreas ( 331 , 333 , 639 ) , PC3 (prostate cell) ( 990 ) , PC9 (pulmonary) ( 177 , 726 , 727 , 728 , 768 , 821 ) , PC9-IR (pulmonary) ( 820 ) , PC9-TAR (pulmonary) ( 770 ) , PL21 (myeloid) ( 915 ) , PLC/PRF/5 (hepatic) ( 468 ) , RD18 (muscle cell) ( 17 ) , RERF-GC-1B (gastric) ( 653 ) , RKO (intestinal) ( 910 ) , SACC-83 (salivary gland) ( 533 , 535 ) , salivary gland ( 510 , 511 , 512 , 513 ) , Saos-2 (bone cell) ( 17 ) , SCH (gastric) ( 669 ) , SEM (B lymphocyte) ( 802 , 803 ) , SH-SY5Y (neural crest) ( 3 , 154 , 155 ) , SJSA-1 (bone cell) ( 702 ) , SK-HEP-1 (endothelial) ( 630 ) , SK-LMS-1 (muscle cell) ( 17 ) , skin ( 240 , 241 , 242 , 243 , 244 , 245 , 246 , 483 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 505 , 517 , 518 , 569 , 571 , 572 , 573 , 589 , 590 , 591 ) , SKNAS (neural crest) ( 3 ) , SKNFI (neural crest) ( 3 ) , SKNSH (neural crest) ( 3 , 883 ) , SMS-KCN-A (neural crest) ( 136 ) , SNB-19 (glial) ( 884 ) , SNU-1 (gastric) ( 834 ) , SNU-1079 (hepatic) ( 506 ) , SNU-1196 (hepatic) ( 504 ) , SNU-182 (hepatic) ( 575 ) , SNU-308 (bile-duct cell) ( 507 ) , SNU-449 (hepatic) ( 450 ) , SNU-478 (bile-duct cell) ( 508 ) , SNU-5 (gastric) ( 788 ) , SNU-C2B (intestinal) ( 832 ) , stomach ( 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 631 , 632 , 633 , 634 , 642 , 643 , 644 , 645 , 646 , 647 , 649 , 650 , 651 , 660 , 661 , 662 ) , Su.86.86 (pancreatic) ( 986 ) , SUP-B15 (B lymphocyte) ( 855 , 1002 ) , SW1710 (bladder cell) ( 767 ) , SW1783 (glial) ( 894 ) , SW480 (intestinal) ( 675 , 676 , 677 , 678 , 679 , 940 ) , SW620 (intestinal) ( 874 , 875 , 941 ) , T98G (glial) ( 911 ) , thymus ( 91 , 92 , 93 , 94 ) , thyroid ( 625 ) , TOV21G (ovarian) ( 853 ) , TYK-nu (ovarian) ( 130 , 144 ) , U-118MG (glial) ( 74 , 83 , 519 , 574 , 970 ) , U-138 MG (glial) ( 813 ) , U2OS (bone cell) ( 17 ) , U87MG (glial) ( 707 ) , UACC-812 (breast cell) ( 105 , 761 , 762 ) , UACC-893 (breast cell) ( 105 ) , UM-UC-1 (bladder cell) ( 814 ) , VACO432 (ovarian) ( 909 ) , WM239A (melanocyte) ( 2 ) , ZR-75-1 (breast cell) ( 105 )

Upstream Regulation
Regulatory protein:
EGFR (human) ( 707 )
Treatments:
ephrin_B1 ( 231 ) , ephrin_B2 ( 231 ) , HGF ( 65 ) , Su11274 ( 229 )

References 

1

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

2

Stuart SA, et al. (2015) A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells. Mol Cell Proteomics 14, 1599-615
25850435   Curated Info

3

Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130
25884760   Curated Info

4

Johnson H, White FM (2014) Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma. J Proteome Res 13, 4581-93
24927040   Curated Info

5

Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94
25159151   Curated Info

6

Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

7

Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

8

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

9

Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

10

Rikova K, Hall B (2013) CST Curation Set: 20742, 21169, 30176, 30177, 30178; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

11

Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

12

Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96
23911959   Curated Info

13

Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

14

Johnson H, et al. (2012) Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Mol Cell Proteomics 11, 1724-40
22964225   Curated Info

15

Rikova K (2012) CST Curation Set: 16140; Year: 2012; Biosample/Treatment: cell line, A549/iressa, gleevec, crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

16

Rikova K (2012) CST Curation Set: 16137; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

17

Bai Y, et al. (2012) Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res 72, 2501-11
22461510   Curated Info

18

Mulhern D (2012) CST Curation Set: 14193; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

19

Zhou J (2012) CST Curation Set: 14105; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

20

Zhou J (2012) CST Curation Set: 14007; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

21

Zhou J (2012) CST Curation Set: 14008; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

22

Zhou J (2012) CST Curation Set: 14009; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

23

Zhou J (2012) CST Curation Set: 14010; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

24

Zhou J (2012) CST Curation Set: 13888; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

25

Zhou J (2012) CST Curation Set: 13889; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

26

Zhou J (2012) CST Curation Set: 13898; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

27

Zhou J (2012) CST Curation Set: 13899; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

28

Mulhern D (2012) CST Curation Set: 13932; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

29

Tucker M (2012) CST Curation Set: 13494; Year: 2012; Biosample/Treatment: cell line, 23132/87/untreated; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

30

Rikova K (2012) CST Curation Set: 13730; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 2/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

31

Zhou J (2012) CST Curation Set: 13689; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

32

Possemato A (2012) CST Curation Set: 13559; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

33

Tucker M (2012) CST Curation Set: 13496; Year: 2012; Biosample/Treatment: cell line, Colo-680N[RAIG1(knockdown)]/GPRC5A knockdown; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

34

Tucker M (2012) CST Curation Set: 13497; Year: 2012; Biosample/Treatment: cell line, Colo-680N/untreated; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

35

Tucker M (2012) CST Curation Set: 13498; Year: 2012; Biosample/Treatment: cell line, OVMANA[RAIG1(knockdown)]/GPRC5A knockdown; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

36

Tucker M (2012) CST Curation Set: 13499; Year: 2012; Biosample/Treatment: cell line, OVMANA[RAIG1(knockdown)]/GPRC5A knockdown; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

37

Tucker M (2012) CST Curation Set: 13501; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

38

Tucker M (2012) CST Curation Set: 13502; Year: 2012; Biosample/Treatment: cell line, OZ[RAIG1(knockdown)]/GPRC5A knockdown; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

39

Tucker M (2012) CST Curation Set: 13503; Year: 2012; Biosample/Treatment: cell line, OZ/untreated; Disease: bile-duct cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

40

Rikova K (2012) CST Curation Set: 13326; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

41

Rikova K (2012) CST Curation Set: 13328; Year: 2012; Biosample/Treatment: cell line, NCI-H1703/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

42

Mulhern D (2012) CST Curation Set: 13331; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

43

Mulhern D (2012) CST Curation Set: 13332; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

44

Mulhern D (2012) CST Curation Set: 13333; Year: 2012; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

45

Mulhern D (2011) CST Curation Set: 13266; Year: 2011; Biosample/Treatment: cell line, K-562/untreated &'||' untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

46

Mulhern D (2011) CST Curation Set: 12645; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

47

Mulhern D (2011) CST Curation Set: 12647; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P Antibodies Used to Purify Peptides prior to LCMS: T*PP Motif (T*PP) (D61C3) Rabbit mAb Cat#: 5757, PTMScan(R) T*PP Motif (T*PP) Immunoaffinity Beads Cat#: 5758
Curated Info

48

Mulhern D (2011) CST Curation Set: 12853; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

49

Mulhern D (2011) CST Curation Set: 12854; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

50

Mulhern D (2011) CST Curation Set: 12855; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

51

Moritz A (2011) CST Curation Set: 12514; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

52

Moritz A (2011) CST Curation Set: 12515; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

53

Moritz A (2011) CST Curation Set: 12516; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

54

Moritz A (2011) CST Curation Set: 12517; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

55

Moritz A (2011) CST Curation Set: 12518; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

56

Moritz A (2011) CST Curation Set: 12519; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

57

Moritz A (2011) CST Curation Set: 12384; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P , PTMScan(R) PLK Binding Motif (SpTP) Immunoaffinity Beads Cat#: 1995
Curated Info

58

Moritz A (2011) CST Curation Set: 12385; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P , PTMScan(R) PLK Binding Motif (SpTP) Immunoaffinity Beads Cat#: 1995
Curated Info

59

Moritz A (2011) CST Curation Set: 12369; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

60

Moritz A (2011) CST Curation Set: 12370; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

61

Moritz A (2011) CST Curation Set: 12371; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

62

Moritz A (2011) CST Curation Set: 12372; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

63

Moritz A (2011) CST Curation Set: 12373; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

64

Moritz A (2011) CST Curation Set: 12374; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

65

Organ SL, et al. (2011) Quantitative Phospho-Proteomic Profiling of Hepatocyte Growth Factor (HGF)-MET Signaling in Colorectal Cancer. J Proteome Res 10, 3200-11
21609022   Curated Info

66

Possemato A (2011) CST Curation Set: 11905; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

67

Possemato A (2011) CST Curation Set: 11906; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

68

Possemato A (2011) CST Curation Set: 11909; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

69

Possemato A (2011) CST Curation Set: 11910; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

70

Possemato A (2011) CST Curation Set: 11911; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

71

Possemato A (2011) CST Curation Set: 11912; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

72

Possemato A (2011) CST Curation Set: 11913; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

73

Possemato A (2011) CST Curation Set: 11914; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

74

Possemato A (2011) CST Curation Set: 11915; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

Possemato A (2011) CST Curation Set: 11917; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

76

Possemato A (2011) CST Curation Set: 11918; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

77

Possemato A (2011) CST Curation Set: 11920; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

78

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

79

Possemato A (2011) CST Curation Set: 11922; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

80

Possemato A (2011) CST Curation Set: 11923; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

Possemato A (2011) CST Curation Set: 11924; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Possemato A (2011) CST Curation Set: 11926; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

Ren H (2011) CST Curation Set: 11781; Year: 2011; Biosample/Treatment: cell line, RP98/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

Ren H (2011) CST Curation Set: 11782; Year: 2011; Biosample/Treatment: cell line, RP99/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Ren H (2011) CST Curation Set: 11784; Year: 2011; Biosample/Treatment: cell line, RP101/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

87

Ren H (2011) CST Curation Set: 11785; Year: 2011; Biosample/Treatment: cell line, RP102/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

88

Ren H (2011) CST Curation Set: 11788; Year: 2011; Biosample/Treatment: cell line, RP105/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

Ren H (2011) CST Curation Set: 11790; Year: 2011; Biosample/Treatment: cell line, FAC 13N/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

90

Ren H (2011) CST Curation Set: 11791; Year: 2011; Biosample/Treatment: cell line, FAC 13T/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

91

Li Y (2011) CST Curation Set: 10458; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

92

Li Y (2011) CST Curation Set: 10459; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

93

Li Y (2011) CST Curation Set: 10460; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

94

Li Y (2011) CST Curation Set: 10461; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

95

Li Y (2011) CST Curation Set: 10520; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

Tucker M (2011) CST Curation Set: 10943; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

97

Tucker M (2011) CST Curation Set: 10945; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

98

Tucker M (2011) CST Curation Set: 10948; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

99

Tucker M (2011) CST Curation Set: 10949; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

100

Tucker M (2011) CST Curation Set: 10950; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

101

Tucker M (2011) CST Curation Set: 10951; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

Tucker M (2011) CST Curation Set: 10952; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

103

Tucker M (2011) CST Curation Set: 10953; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

104

Chumbalkar V, et al. (2011) Analysis of Phosphotyrosine Signaling in Glioblastoma Identifies STAT5 as a Novel Downstream Target of ΔEGFR. J Proteome Res 10, 1343-52
21214269   Curated Info

105

Albeck JG, Brugge JS (2011) Uncovering a tumor suppressor for triple-negative breast cancers. Cell 144, 638-40
21376226   Curated Info

106

Ren H (2011) CST Curation Set: 11303; Year: 2011; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

Li Y (2011) CST Curation Set: 10455; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

Li Y (2011) CST Curation Set: 10448; Year: 2011; Biosample/Treatment: heart, cardiac/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

Li Y (2011) CST Curation Set: 10501; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

Li Y (2011) CST Curation Set: 10452; Year: 2011; Biosample/Treatment: heart, cardiac/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

111

Li Y (2011) CST Curation Set: 10454; Year: 2011; Biosample/Treatment: heart, cardiac/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

Moritz A (2011) CST Curation Set: 11304; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

113

Moritz A (2011) CST Curation Set: 11305; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

Moritz A (2011) CST Curation Set: 11307; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

Moritz A (2011) CST Curation Set: 11308; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

Moritz A (2011) CST Curation Set: 11309; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

117

Moritz A (2011) CST Curation Set: 11310; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

118

Moritz A (2011) CST Curation Set: 11311; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

119

Moritz A (2011) CST Curation Set: 11312; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

Gu TL, et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6, e15640
21253578   Curated Info

121

Ding VM, et al. (2011) Tyrosine phosphorylation profiling in fgf-2 stimulated human embryonic stem cells. PLoS One 6, e17538
21437283   Curated Info

122

Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5
21712546   Curated Info

123

Gu TL, et al. (2011) Survey of activated FLT3 signaling in leukemia. PLoS One 6, e19169
21552520   Curated Info

124

Tucker M (2010) CST Curation Set: 10852; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Tucker M (2010) CST Curation Set: 10854; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

126

Ren H (2010) CST Curation Set: 10743; Year: 2010; Biosample/Treatment: cell line, OVKATE/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

127

Ren H (2010) CST Curation Set: 10744; Year: 2010; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

128

Ren H (2010) CST Curation Set: 10740; Year: 2010; Biosample/Treatment: cell line, OVKATE/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

129

Ren H (2010) CST Curation Set: 10754; Year: 2010; Biosample/Treatment: cell line, OVMIU/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

130

Ren H (2010) CST Curation Set: 10751; Year: 2010; Biosample/Treatment: cell line, TYK-nu/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

131

Ren H (2010) CST Curation Set: 10741; Year: 2010; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

132

Ren H (2010) CST Curation Set: 10750; Year: 2010; Biosample/Treatment: cell line, OVTOKO/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

133

Ren H (2010) CST Curation Set: 10745; Year: 2010; Biosample/Treatment: cell line, MCAS/serum starved; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

134

Knowlton ML, et al. (2010) Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells. PLoS One 5, e13587
21049007   Curated Info

135

Iliuk AB, et al. (2010) In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers. Mol Cell Proteomics 9, 2162-72
20562096   Curated Info

136

Guo A (2010) CST Curation Set: 10553; Year: 2010; Biosample/Treatment: cell line, SMS-KCN-A/untreated; Disease: neuroblastoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

137

Tucker M (2010) CST Curation Set: 10308; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

138

Tucker M (2010) CST Curation Set: 10314; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

139

Tucker M (2010) CST Curation Set: 10307; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

140

Tucker M (2010) CST Curation Set: 10312; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

141

Ren H (2010) CST Curation Set: 10183; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

142

Ren H (2010) CST Curation Set: 10180; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

143

Ren H (2010) CST Curation Set: 10179; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

144

Tucker M (2010) CST Curation Set: 10086; Year: 2010; Biosample/Treatment: cell line, TYK-nu/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

145

Tucker M (2010) CST Curation Set: 10082; Year: 2010; Biosample/Treatment: cell line, OVTOKO/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

146

Tucker M (2010) CST Curation Set: 10085; Year: 2010; Biosample/Treatment: cell line, OVTOKO/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

147

Tucker M (2010) CST Curation Set: 10091; Year: 2010; Biosample/Treatment: cell line, OVCAR8/untreated; Disease: ovarian cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

148

Moritz A (2010) CST Curation Set: 10238; Year: 2010; Biosample/Treatment: cell line, MKN-45/DMSO; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

149

Moritz A (2010) CST Curation Set: 10232; Year: 2010; Biosample/Treatment: cell line, MKN-45/Su11274; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

150

Moritz A (2010) CST Curation Set: 10231; Year: 2010; Biosample/Treatment: cell line, MKN-45/Su11274; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

151

Guo A (2010) CST Curation Set: 10131; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

152

Ren H (2010) CST Curation Set: 10132; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

153

Ren H (2010) CST Curation Set: 10133; Year: 2010; Biosample/Treatment: tissue, ovary/untreated; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411
Curated Info

154

Rikova K (2010) CST Curation Set: 10078; Year: 2010; Biosample/Treatment: cell line, SH-SY5Y/inhibitor; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

155

Rikova K (2010) CST Curation Set: 10076; Year: 2010; Biosample/Treatment: cell line, SH-SY5Y/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

156

Rikova K (2010) CST Curation Set: 10040; Year: 2010; Biosample/Treatment: cell line, DFCI ERC17/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

157

Rikova K (2010) CST Curation Set: 10044; Year: 2010; Biosample/Treatment: cell line, DFCI ERC17 triple/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

158

Rikova K (2010) CST Curation Set: 10028; Year: 2010; Biosample/Treatment: cell line, HCC827/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

159

Moritz A (2010) CST Curation Set: 10021; Year: 2010; Biosample/Treatment: cell line, MKN-45/DMSO; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

160

Moritz A (2010) CST Curation Set: 10020; Year: 2010; Biosample/Treatment: cell line, MKN-45/DMSO; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

161

Moritz A (2010) CST Curation Set: 10022; Year: 2010; Biosample/Treatment: cell line, MKN-45/Su11274; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

162

Possemato A (2010) CST Curation Set: 9956; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

163

Possemato A (2010) CST Curation Set: 9955; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

164

Possemato A (2010) CST Curation Set: 9954; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

165

Possemato A (2010) CST Curation Set: 9953; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

166

Possemato A (2010) CST Curation Set: 9858; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

167

Possemato A (2010) CST Curation Set: 9859; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

168

Possemato A (2010) CST Curation Set: 9857; Year: 2010; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: